Akebia Therapeutics, Inc. (AKBA) vs High Tide Inc. (HITI)
A side-by-side comparison of Akebia Therapeutics, Inc. and High Tide Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKBA
Akebia Therapeutics, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
HITI
High Tide Inc.
$2.74HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — AKBA vs HITI
growth of $100 · dividends reinvested · last 8yAKBA -84.6% (-20.8%/yr)HITI -32.8% (-4.9%/yr)HITI compounded faster over this window
AKBA HITI
AKBA vs HITI: by the numbers
- •AKBA is the larger company ($242M vs $241M market cap).
- •Both run net losses; HITI's is the smaller (-4.52% vs -13.54% net margin).
- •HITI grew revenue faster over the past five years (33.84% vs -0.26% CAGR).
Metrics side by side
Valuation
| Metric | AKBA | HITI |
|---|---|---|
| P/S ratio | 1.10 | 0.46 |
| P/B ratio | 9.66 | 3.21 |
| EV / EBITDA | N/A | 12.96 |
| FCF yield | 16.62% | 4.77% |
Profitability
| Metric | AKBA | HITI |
|---|---|---|
| Gross margin | 79.48% | 25.85% |
| Operating margin | 9.95% | 0.56% |
| Net margin | -13.54% | -4.52% |
| ROE | -118.58% | -31.55% |
| ROIC | -7.08% | 1.38% |
Growth (annualized)
| Metric | AKBA | HITI |
|---|---|---|
| Revenue CAGR (5Y) | -0.26% | 33.84% |
| Total return CAGR (5Y) | -20.07% | -14.29% |
Frequently asked
- Which has grown faster, AKBA or HITI?
- Over the past five years, HITI grew revenue faster — AKBA at a -0.26% CAGR versus HITI at 33.84%.
- How have AKBA and HITI total returns compared?
- Over the past 5 years, AKBA delivered -20.07% and HITI delivered -14.29% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Akebia Therapeutics ROEHigh Tide ROEAkebia Therapeutics operating marginHigh Tide operating marginAkebia Therapeutics revenue growthHigh Tide revenue growthAkebia Therapeutics free cash flowHigh Tide free cash flow
Akebia Therapeutics & High Tide appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.